The final activation gate for support and logistics is proving that the new or renovated space can run safely the moment it opens — that construction-borne infection risk has been contained and verified, that regulated waste and hazardous-material streams are correctly segregated and contained from day one, and that the facility can keep operating, or fail safely, when a utility, supply chain, or staffing disruption hits. These three readiness domains share a common trait: they are largely invisible when they work and catastrophic when they do not, and each is enforced by an Authority Having Jurisdiction (AHJ), an accreditor, or both.
This Article covers the infection-control discipline that governs construction and activation (the ICRA process), the design and operational verification of regulated medical waste and hazardous-material handling, and the business-continuity and emergency-operations readiness that a support-services footprint must demonstrate before go-live. It deliberately stays out of the lane of its siblings: detailed SPD process flow and supply-chain stand-up, integrated utilities commissioning and systems testing, and sterilizer/biological-indicator validation are addressed in their own articles. The focus here is on safety containment, waste regulation, and continuity readiness as activation deliverables.
In an operating healthcare facility, any construction, renovation, maintenance, or even minor activity that disturbs walls, ceilings, floors, or building systems is a potential source of healthcare-associated infection — most acutely from Aspergillus and other fungal spores liberated during demolition, and from waterborne organisms such as Legionella disturbed by plumbing work. The discipline that controls this is the Infection Control Risk Assessment (ICRA), a structured pre-construction and through-construction process required by the FGI Guidelines for Design and Construction and enforced by accreditors (The Joint Commission, DNV) under the physical-environment and infection-prevention standards, and by CMS Conditions of Participation.
The current FGI Guidelines reference the ASHE/AHA ICRA 2.0 matrix methodology, which structures the assessment as a sequence:
The ICRA is authored jointly by the infection preventionist, facilities/engineering, safety, the design team, and the contractor; it is a living document that is revisited whenever the scope, location, or adjacent occupancy changes. For activation specifically, the ICRA does not end when construction does — it governs the transition from "construction zone" to "clinical-ready clean space," including the terminal cleaning, air-quality verification, and barrier-removal sequence that must occur before the space can be turned over.
The higher ICRA classes translate into engineered, inspectable site conditions. The owner, PMO, and infection preventionist should treat these as verifiable deliverables with hold points, not as contractor self-attestation:
Two interfaces deserve particular attention during activation. First, water and Legionella management: when plumbing is opened, capped, modified, or a building section sits stagnant during construction, the facility's ASHRAE 188 water-management program governs flushing, disinfection, and (where indicated) sampling before the system serves patients — this is a CMS expectation for reducing Legionella risk and must be sequenced into commissioning. Second, the pressure-cascade and air-change verification that the new clinical and support spaces (ORs, SPD, AIIRs, pharmacy compounding) must demonstrate per ASHRAE 170 and FGI before occupancy — verifying that the design intent (e.g., positive pressure for ORs and the SPD clean side, negative for soiled-utility and decontamination, the SPD pressure cascade) is actually achieved. That air-balance and pressure verification is part of integrated systems testing and is detailed in the commissioning sibling Article; what belongs here is the infection-control sign-off that those conditions are met before the space is cleared for patient use.